Author Topic: (Abst.) [Tecfidera] treatment in RRMS changes inflammatory CSF protein profile...  (Read 1136 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9817
  • MS diagnosed 1980
  • Location: Pacific Northwest
From PubMed (November 13, 2023)--"Dimethyl fumarate treatment in relapsing remitting MS changes the inflammatory CSF protein profile by a prominent decrease in T-helper 1 immunity":


https://pubmed.ncbi.nlm.nih.gov/37952502/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
141 Views
Last post June 08, 2018, 09:06:06 pm
by agate
1 Replies
129 Views
Last post August 26, 2020, 07:25:46 pm
by agate
0 Replies
60 Views
Last post October 11, 2020, 02:50:55 pm
by agate
0 Replies
37 Views
Last post May 09, 2021, 09:37:37 pm
by agate
0 Replies
57 Views
Last post September 06, 2021, 09:10:08 pm
by agate